NovaMatrix® manufacture PRONOVA® sodium alginate in our facilities in Norway. We operate according to GMP guidelines and ISO standards; ISO 9001:2015 and ISO 13485:2016. Furthermore NovaMatrix holds the Manufacturing License for API’s issued by the Norwegian Medicine Agency (NOMA).